Publication: Characterization of two siderophores produced by Bacillus megaterium: A preliminary investigation into their potential as therapeutic agents
Issued Date
2020-10-01
Resource Type
ISSN
18728006
03044165
03044165
Other identifier(s)
2-s2.0-85086720736
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Biochimica et Biophysica Acta - General Subjects. Vol.1864, No.10 (2020)
Suggested Citation
Hataichanok Chuljerm, Manu Deeudom, Suthat Fucharoen, Francesca Mazzacuva, Robert C. Hider, Somdet Srichairatanakool, Agostino Cilibrizzi Characterization of two siderophores produced by Bacillus megaterium: A preliminary investigation into their potential as therapeutic agents. Biochimica et Biophysica Acta - General Subjects. Vol.1864, No.10 (2020). doi:10.1016/j.bbagen.2020.129670 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/57673
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Characterization of two siderophores produced by Bacillus megaterium: A preliminary investigation into their potential as therapeutic agents
Other Contributor(s)
Abstract
© 2020 Elsevier B.V. Background: Microorganisms produce siderophores in order to scavenge iron from the environment and this study focuses on the characterization of the two siderophores secreted by Bacillus megaterium. The general biological properties and pharmacokinetics following oral application of these compounds are reported. Methods: Under optimized culture conditions, the siderophores were harvested, purified by chromatography and identified using LC-MS and NMR. Two dihydroxamate siderophores were isolated, schizokinen (MW = 420) and schizokinen imide (MW = 402). Results: Both compounds demonstrate strong antioxidant activity and were found to be relatively nontoxic to both human hepatocellular carcinoma (Huh7) and peripheral blood mononuclear cells. The siderophores possess a strong affinity for iron(III) and decrease the levels of the labile iron pool (LIP) in iron-loaded cells in a concentration-dependent manner. Schizokinen, was detected as both the free siderophore and the iron complex in the plasma and urine of rats after oral gavage. Conclusions: However, the bioavailability was low and thus schizokinen, like deferoxamine, has no potential as an orally active iron chelator for the treatment of systemic iron overload. General significance: By virtue of the high affinity of schizokinen for tribasic metals, this siderophore does have considerable potential for the chelation of gallium(III) and the development of clinical diagnostic reagents.